A direct antiviral product called AREPLIVIR is used to treat COVID-19 of any severity.
RNA-dependent RNA polymerase (RdRp), an enzyme required for viral replication, is inhibited by the product Areplivir. Created in Japan to treat various strains of influenza that are unresponsive to current treatments.OMICRON, DELTA, AND 11 OTHER VARIANTS ARE MUTATIONS OF THE SARS-COV-2 PATHOGEN, AND AREPLIVIR SUPPRESSES ANY RNA VIRUSES COVID-19. AS WITH MOST ACUTE RESPIRATORY VIRUSES, COVID-19 IS AN RNA VIRUS (RHINOVIRUS, INFLUENZA VIRUS, PARAINFLUENZA, RESPIRATORY SYNCYTIAL VIRUS, BOCAVIRUS)
ACTIONS THROUGH A DOUBLE MECHANISM: It IMPROVES CLINICAL STATUS AND LUNG STATUS ON CT SCAN IN MORE THAN 90% OF PATIENTS AND INHIBITS VIRUS REPLICATION AND ACCELERATES ITS ELIMINATION BY UP TO 3 DAYS AND DEMONSTRATES A FAVORABLE SAFETY PROFILE.
AREPLIVIR 40 tab / АРЕПЛИВИР 40 таб
Products might cost different amounts at a pharmacy and online. The image of the product may differ from the actual product.
